Blog

T cells are immune system guardians. Biointron explains their functions, origins, and therapeutic applications in immunology and cancer treatment.

Recombinant proteins drive innovation in biotech. Biointron reviews how they are produced and applied in therapeutics, diagnostics, and scientific research.

Recombinant antibodies offer precision and consistency. Biointron outlines how DNA technology produces synthetic antibodies for research and clinical applications.

Polyclonal antibodies are diverse and versatile. Biointron explains their production, uses in research, and importance in diagnostics and therapeutic development.

Immunotherapies harness the immune system to fight disease. Biointron reviews their role in oncology and beyond, transforming treatment strategies worldwide.

Explore how Biointron’s AbDrop™ platform combines microfluidics, single B cell screening, and NGS to accelerate antibody discovery and therapeutic development.

Human antibody discovery strengthens pipelines. Biointron provides cost-effective solutions using advanced platforms and transgenic models.

High-purity antibodies are vital for reliable research. Biointron emphasizes quality control to prevent misleading results and accelerate discoveries.

In vivo antibody testing validates therapies. Biointron highlights methods to evaluate efficacy and safety before clinical application.

Assays measure biological activity, concentration, and presence. Biointron highlights their essential role in validating antibodies and advancing research and therapeutics.

Phagocytosis enables cells to engulf pathogens. Biointron explains this process and its importance in immunity and therapeutic design.

Monomeric antibodies are the classic IgG format. Biointron outlines their structure, function, and role in therapy and diagnostics.